{"meshTags":["Animals","Cell Transformation, Neoplastic","Drosophila melanogaster","Exons","Gene Expression Regulation","Humans","Mutation","Neoplasms","PTEN Phosphohydrolase","Parkinson Disease","Signal Transduction"],"meshMinor":["Animals","Cell Transformation, Neoplastic","Drosophila melanogaster","Exons","Gene Expression Regulation","Humans","Mutation","Neoplasms","PTEN Phosphohydrolase","Parkinson Disease","Signal Transduction"],"genes":["PTEN","PTEN","phosphatase","tensin homolog","PTEN","PTEN"],"organisms":["9606"],"publicationTypes":["Journal Article","Research Support, Non-U.S. Gov\u0027t","Review"],"abstract":"Mutations of the tumour suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10) are seen in many human cancers. However, dysregulation of PTEN may be involved in other disease states such as Parkinson\u0027s disease. This minireview describes recent work examining PTEN regulation and its implications for the development of both cancer and neurodegenerative disease.","title":"Tumours and tremors: how PTEN regulation underlies both.","pubmedId":"16495927"}